These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3117634)

  • 1. Alpha recombinant interferon in the treatment of mycosis fungoides (MF).
    Tura S; Mazza P; Zinzani PL; Ghetti PL; Poletti G; Gherlinzoni F; Montagnani A; Criscuolo D
    Haematologica; 1987; 72(4):337-40. PubMed ID: 3117634
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
    Vonderheid EC; Thompson R; Smiles KA; Lattanand A
    Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha-associated development of bullous lesions in mycosis fungoides.
    Pföhler C; Ugurel S; Seiter S; Wagner A; Tilgen W; Reinhold U
    Dermatology; 2000; 200(1):51-3. PubMed ID: 10681616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series.
    Nikolaou V; Siakantaris MP; Vassilakopoulos TP; Papadavid E; Stratigos A; Economidi A; Marinos L; Papadaki T; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):354-7. PubMed ID: 20586838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate.
    Thestrup-Pedersen K; Hammer R; Kaltoft K; Søgaard H; Zachariae H
    Br J Dermatol; 1988 Jun; 118(6):811-8. PubMed ID: 3042011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
    Foon KA; Bunn PA
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta interferon in the treatment of mycosis fungoides.
    Zinzani PL; Mazza P; Gherlinzoni F
    Haematologica; 1988; 73(6):547-8. PubMed ID: 3148521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
    Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
    Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
    Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
    Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
    Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
    J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides.
    Braathen LR; Stavem P
    BMJ; 1989 Jun; 298(6689):1713. PubMed ID: 2503190
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.
    Averbuch SD; Austin HA; Sherwin SA; Antonovych T; Bunn PA; Longo DL
    N Engl J Med; 1984 Jan; 310(1):32-5. PubMed ID: 6689738
    [No Abstract]   [Full Text] [Related]  

  • 19. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL; Kenney P; Young D; Rinehart JJ
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.